Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 580

1.

Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.

Kanswal S, Katsenelson N, Selvapandiyan A, Bram RJ, Akkoyunlu M.

J Immunol. 2008 Jul 15;181(2):976-90. Erratum in: J Immunol. 2008 Oct 1;181(7):5174.

2.

Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.

Katsenelson N, Kanswal S, Puig M, Mostowski H, Verthelyi D, Akkoyunlu M.

Eur J Immunol. 2007 Jul;37(7):1785-95.

3.

TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.

Bossen C, Cachero TG, Tardivel A, Ingold K, Willen L, Dobles M, Scott ML, Maquelin A, Belnoue E, Siegrist CA, Chevrier S, Acha-Orbea H, Leung H, Mackay F, Tschopp J, Schneider P.

Blood. 2008 Feb 1;111(3):1004-12. Epub 2007 Oct 17.

4.

TACI regulates IgA production by APRIL in collaboration with HSPG.

Sakurai D, Hase H, Kanno Y, Kojima H, Okumura K, Kobata T.

Blood. 2007 Apr 1;109(7):2961-7.

5.

Suppressive effect of bacterial polysaccharides on BAFF system is responsible for their poor immunogenicity.

Kanswal S, Katsenelson N, Allman W, Uslu K, Blake MS, Akkoyunlu M.

J Immunol. 2011 Feb 15;186(4):2430-43. doi: 10.4049/jimmunol.1002976. Epub 2011 Jan 19.

6.

In vitro and in vivo activation induces BAFF and APRIL expression in B cells.

Chu VT, Enghard P, Riemekasten G, Berek C.

J Immunol. 2007 Nov 1;179(9):5947-57.

7.

TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.

Mackay F, Schneider P.

Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):263-76. doi: 10.1016/j.cytogfr.2008.04.006. Epub 2008 Jun 2. Review.

PMID:
18514565
8.

TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens.

Mantchev GT, Cortesão CS, Rebrovich M, Cascalho M, Bram RJ.

J Immunol. 2007 Aug 15;179(4):2282-8.

9.

Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.

Lee JJ, Ozcan E, Rauter I, Geha RS.

Curr Opin Allergy Clin Immunol. 2008 Dec;8(6):520-6. doi: 10.1097/ACI.0b013e3283141200. Review.

PMID:
18978466
10.

Identification of proteoglycans as the APRIL-specific binding partners.

Ingold K, Zumsteg A, Tardivel A, Huard B, Steiner QG, Cachero TG, Qiang F, Gorelik L, Kalled SL, Acha-Orbea H, Rennert PD, Tschopp J, Schneider P.

J Exp Med. 2005 May 2;201(9):1375-83. Epub 2005 Apr 25.

11.

Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.

Day ES, Cachero TG, Qian F, Sun Y, Wen D, Pelletier M, Hsu YM, Whitty A.

Biochemistry. 2005 Feb 15;44(6):1919-31.

PMID:
15697217
12.

Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice.

Uslu K, Coleman AS, Allman WR, Katsenelson N, Bram RJ, Alugupalli KR, Akkoyunlu M.

J Immunol. 2014 Apr 15;192(8):3582-95. doi: 10.4049/jimmunol.1203468. Epub 2014 Mar 19.

13.

Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen.

Schneider P, Takatsuka H, Wilson A, Mackay F, Tardivel A, Lens S, Cachero TG, Finke D, Beermann F, Tschopp J.

J Exp Med. 2001 Dec 3;194(11):1691-7.

14.

Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates.

Kaur K, Chowdhury S, Greenspan NS, Schreiber JR.

Blood. 2007 Oct 15;110(8):2948-54. Epub 2007 Jul 18.

15.

APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.

Moreaux J, Sprynski AC, Dillon SR, Mahtouk K, Jourdan M, Ythier A, Moine P, Robert N, Jourdan E, Rossi JF, Klein B.

Eur J Haematol. 2009 Aug;83(2):119-29. doi: 10.1111/j.1600-0609.2009.01262.x. Epub 2009 May 30.

PMID:
19456850
16.

Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.

Ozcan E, Garibyan L, Lee JJ, Bram RJ, Lam KP, Geha RS.

J Allergy Clin Immunol. 2009 Jun;123(6):1277-86.e5. doi: 10.1016/j.jaci.2009.03.019. Epub 2009 May 8.

17.

Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency.

Jin R, Kaneko H, Suzuki H, Arai T, Teramoto T, Fukao T, Kondo N.

Int J Mol Med. 2008 Feb;21(2):233-8.

PMID:
18204790
18.

BAFF, APRIL and their receptors: structure, function and signaling.

Bossen C, Schneider P.

Semin Immunol. 2006 Oct;18(5):263-75. Epub 2006 Aug 17. Review.

PMID:
16914324
19.

TACI attenuates antibody production costimulated by BAFF-R and CD40.

Sakurai D, Kanno Y, Hase H, Kojima H, Okumura K, Kobata T.

Eur J Immunol. 2007 Jan;37(1):110-8.

20.

Macrophage- and dendritic cell--dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF.

Craxton A, Magaletti D, Ryan EJ, Clark EA.

Blood. 2003 Jun 1;101(11):4464-71. Epub 2003 Jan 16.

Supplemental Content

Support Center